ŠΦ“Œ˜A‡ŽY‰Θ•wl‰ΘŠw‰ο
‰οˆυƒƒOƒCƒ“ ‘γ•\ˆ₯ŽA
‘‰οEŠwpW‰ο
Šw‰οŽ
’θŠΌ
Œφ
—˜‰v‘Š”½
–πˆυ\¬
Ž––±‹ΗˆΔ“ΰ
‹lŽ{έˆκ——
ŠΦ˜AƒŠƒ“ƒN

@ŠΦ“Œ˜A‡ŽY‰Θ•wl‰ΘŠw‰ο‰οŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹

<< Šw‰οŽ‚Φ–ί‚ι
<< ‘O‚Μƒy[ƒW‚Φ–ί‚ι

‘ζ99‰ρŠwpW‰οi•½¬12”N6ŒŽ10“ϊj

yˆκ”Κ‰‰‘θz
—‘‘ƒŽξᇁi4j
CarboplatinEPaclitaxel—Γ–@‚ͺ‘tŒψ‚΅‚½normal-sized ovary carcinomasyndrome‚Μ1—α

HΰV@f, –@³ƒ, •ž•”@”ό“ήŽq, ˆΐ’B@’mŽq, ‘Ύ“c@”Ž–Ύ
“Œ‹ž—Žqˆγ‰Θ‘εŠwŽY•wl‰Θ


“ϊ–{ŽY‰Θ•wl‰ΘŠw‰οŠΦ“Œ˜A‡’n•ϋ•”‰ο‰ο•ρ, 37(2) 202-202, 2000

Page Topͺ
ˆκ”ΚŽΠ’c–@lŠΦ“Œ˜A‡ŽY‰Θ•wl‰ΘŠw‰οŽ––±‹Η@§102-0083 “Œ‹ž“sη‘γ“c‹ζ’¬4-7 ’¬ƒp[ƒNƒTƒCƒhƒrƒ‹402 Š”)MAƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒRƒ“ƒTƒ‹ƒeƒBƒ“ƒO“ΰ
TELF03-3288-0993@FAXF03-5275-1192@E-mailFkantorengo@jsog-k.jp
Copyright (C) ˆκ”ΚŽΠ’c–@lŠΦ“Œ˜A‡ŽY‰Θ•wl‰ΘŠw‰ο